RapidLabs Information

RapidLabs provides the ability to report both ID and AST results in 30 minutes. Current commercially available products are able to provide complete ID results in 3-15 hours and AST results in 7.5-16 hours. This decreased time to results of 2.5-16 hours will drive more appropriate prescribing practices, reduce the number of additional tests performed on a patient, and will allow the patient to leave the hospital sooner, saving the hospital significant money. RapidLabs streamlines the operations of the lab. In addition to testing members of the Enterobacteriaceae and other non-fermenting gram-negative bacilli, Staphylococcus, Streptococcus and Enterococcus groups of bacteria, which the current commercially available systems can manage, the RapidLabs system will also be able to test a wide range of other microbes include Gram-Positive bacilli, fastidious Gram Negatives, anaerobes, fungi and yeasts. Test preparation and results reporting will be standardized for a broader set of organisms, reducing the number of third party test kits, reducing the clutter on the desk of the lab tech, and improving the efficiency of the lab tech. RapidLabs provides identification to the species and strain level for most of the commonly pathogenic microorganisms. This additional specificity will provide the physicians with additional detail to ensure their understanding of the origin of the infection and the treatment options. The RapidLabs applications and technologies are based on respiration. We have developed a technology based on cell membrane electron transfer rather than cell proliferation. This fundamental difference allows RapidLabs to provide results to both ID and AST tests within 30 minutes.